Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
Recruiting · NCT06528691 · Registry updated 2026-05-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, central nervous system cancer, central nervous system neoplasm, epithelial neoplasm, glioma, malignant glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-05-13 | NCT06528691 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hoffmann-La Roche | 280 |
| St. Jude Children's Research Hospital | 169 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| GRAACC Hospital (Grupo de Apoio ao Adolescente e à Criança com Câncer) | São Paulo | Brazil | 1 |
| Hospital de Câncer de Barretos | Barretos | Brazil | 1 |
| Hospital Santa Marcelina | São Paulo | Brazil | 6 |
| Instituto Nacional de Enfermedades Neoplásicas | Lima | Peru | 1 |
| King Hussein Cancer Center | Amman | Jordan | 7 |
| St. Jude Children's Research Hospital | Memphis | United States | 194 |